Personalized Medicine News, Articles

Our findings suggest that mRNA vaccines may provide just the spark the immune system needs to turn “cold” tumors “hot.”

COVID-19 mRNA Vaccines Could Unlock the Next Revolution in Cancer Treatment—New Research

Christiano Marconi, Adam Grippin, MD, PhD

With a little help, your immune cells can be potent tumor killers

The ability of 3D printing to make precisely shaped objects in a wide range of materials has led to, for example, custom replacement joints and custom-dosage, multidrug pills.

How 3D Printing Is Personalizing Health Care

Anne Schmitz, PhD, Daniel Freedman, PhD

Exploring the lab-driven innovations behind custom implants, drug delivery, and diagnostic tools

A critical challenge in treating, researching, and living with multiple sclerosis is that MRI and neurological exams identify disease changes only after they have occurred.

The Future of Biomarkers in Multiple Sclerosis Care

Stephanie Buxhoeveden, PhD, MSN, FNP-BC, MSCN

MS expert Stephanie Buxhoeveden combines personal experience with scientific expertise to explore how biomarkers are transforming MS care

Hologic to Present New Data at ASCO 2025 on the Breast Cancer Index® Test’s Role in Personalized Care

Hologic

Assessment of over 2,800 patients highlights the profound impact of the BCI test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer

Scientist holding a flask of water with a green background

Reducing Waste and Energy Use in Clinical Diagnostics

ELGA

Innovative wastewater treatment methods helping labs reduce environmental impact

Photo of two infectious disease researchers wearing full PPE examining a sample from a COVID-19 patient. caption:

Genetic Insights into COVID-19 Severity: The Role of PAI-1 Polymorphisms

Today's Clinical Lab

A recent study reveals how PAI-1 gene polymorphisms are linked to severe COVID-19 outcomes

Illustration and abstract photo of the gloved hands of a clinical researcher pipetting and culturing cells derived from patients to create patient-derived xenograft models.

Capturing the Complexity of Real Cancer Cases with Patient-Derived Xenograft Models

Michael J. Wick, PhD

Patient-derived xenograft models enable researchers to explore novel therapies and diagnostic tools within the context of specific mutational signatures, treatment histories, and more

Microscope image of 3D organoids cultured from esophageal cancer.

Unlocking the Potential of Patient-Derived Organoids for Personalized Sarcoma Treatment

UCLA Health

By using 3D mini tumor models that closely resemble a patient's tumor, treatments could be tailored more effectively, paving the way for more personalized cancer treatments